The American Society of Clinical Oncology is launching an internship program for medical students from populations underrepresented in medicine.
City of Hope has signed an education agreement with Hospital Israelita Albert Einstein, a cancer center in Brazil.
The Pascale Foundation (Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”) has joined the Caris Precision Oncology Alliance.
Matthew Vander Heiden, an MIT professor of biology was named the director of MIT’s Koch Institute for Integrative Cancer Research, effective April 1.Vander Heiden will succeed Tyler Jacks, who has served as director for more than 19 years, first for the MIT Center for Cancer Research and then for its successor, the Koch Institute.
Lucile Adams-Campbell received the Joseph F. Fraumeni, Jr., Distinguished Achievement Award, and Carolyn “Bo” Aldigé received the Joseph W. Cullen Memorial Award during the American Society of Preventive Oncology annual meeting March 29-April 1.
Narjust Duma was named associate director of the Cancer Care Equity Program at Dana-Farber Cancer Institute and Harvard Medical School, effective Aug. 2.
Neeraj Agarwal was named senior director of clinical research innovation at Huntsman Cancer Institute at the University of Utah.
Amy Abernethy is leaving her positions as FDA principal deputy commissioner and acting chief information officer in mid- to late April, the agency said.
John C. Byrd, the D. Warren Brown Chair of Leukemia Research at the Ohio State University College of Medicine, was named professor and chair of the University of Cincinnati College of Medicine Department of Internal Medicine.
Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital have established the Brain Tumor Center, to provide care for brain tumor patients while also developing transformative basic, translational and clinical research to develop new therapies and improve patient outcomes.
